Navigation Links
Helping back pain sufferers to stay in work
Date:2/22/2008

New research to be carried out at The University of Nottingham could have a major impact on the way that people struggling with low back pain are helped to stay in work.

Back pain is one of the main causes of absence from work in the UK. In 2004-5 approximately 34,000 people in the East Midlands suffered from musculoskeletal disorders affecting their backs, which they believed were caused or made worse by their current or past work.

Now medical research charity the Arthritis Research Campaign has awarded a three-year primary care fellowship of almost 132,000 to occupational therapist Carol Coole at The University of Nottingham, to develop more effective ways in which the NHS can work with employees with back pain and their employers to ensure that back pain doesnt drive them away from the workplace.

In some areas of the UK, patients receive vocational rehabilitation to help them improve their ability to work. However, this service is patchy and ad hoc, and very few people with back pain have access to it.

Since 2000 the Nottingham Back Team physiotherapists, occupational therapists, nurses, cognitive behavioural therapists and psychologists based at the City Hospital has run regular group classes at local leisure centres. The programme, offered to some 700 people a year who have had back pain for more than three months, involves graded exercises and activities, relaxation techniques and educational packages.

Mrs Coole, who is based at The University of Nottinghams division of rehabilitation and ageing, now aims to find out if extra support would also be of benefit, such as running more tailored, work-focused sessions with individual employees, and liaising much more closely with employers and job centres.

She said: It can be difficult for employees who are worried that work might make their back pain worse, and also for employers who want the back pain to be cured and dont understand that its a chronic c
'/>"/>

Contact: Carol Coole
Carolyn.coole@nottingham.ac.uk
University of Nottingham
Source:Eurekalert

Page: 1 2

Related biology news :

1. Conference to examine role technology can play in helping US manage healthcare costs
2. A helping hand from the grandparents
3. New Swedish research hope for millions of sufferers
4. New hope for hepatitis C sufferers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... scientists from 25 countries and 35 states will ... the Genetics Society of America (GSA) next week ... conference will feature close to 500 presentations (including ... including gene expression and regulation, functional genomics, chemical ... and a variety of diseases. , Of ...
(Date:7/25/2014)... pleiotropic factor characterized by the existence of numerous ... confer to the protein deeply different characteristics. NRG1 ... occurring during development and the different phases occurring ... axon regrowth, remyelination and target reinnervation, Researchers at ... the soluble NRG1 upregulation observed in Schwann cells ...
(Date:7/25/2014)... KANSAS CITY, MOResearchers at the Stowers Institute for ... classes of pheromone receptors, and found pheromones crucial to ... one class of receptors helps a male mouse detect ... other class of receptors lets him know if the ... sets of pheromones are critical to trigger mating. Stowers, ...
Breaking Biology News(10 mins):Yeast meeting to showcase latest breakthroughs in genetics and molecular biology 2It takes two to court 2It takes two to court 3
... loss of dopamine neurons is a hallmark of many ... Stem cell biology and regenerative medicine offer novel therapies ... the online open-access journal PLoS Biology Dr. Raja Kittappa, ... McKay show that the transcription factor FOXA2 plays a ...
... invasive plant species is complex, to say the least. ... create conditions that promote population explosions of invasive plants, ... to the ecosystems they inhabit. On the other, fire ... growth. A new general technical report published by ...
... New microscopic pictures show the first-ever physical evidence ... (CF) disease. Researchers at the University of Alabama ... protein called epithelial sodium channel, or ENaC. Both proteins ... exactly what role each plays is unclear. ...
Cached Biology News:Cystic fibrosis proteins photographed interacting 2
(Date:7/24/2014)... MENLO PARK, Calif. , July 24, 2014 ... biotechnology company in the emerging field of regenerative ... live webcast of a presentation to investors on ... 1:30 p.m. PDT.  The presentation will include an ... pipeline. To access the webcast, visit http://www.ustream.tv/channel/asterias-biotherapeutics ...
(Date:7/24/2014)... Distinguished Professor of Engineering at the University of ... solve problems in energy engineering, environmental sustainability and ... zeolites, porous rock with a well-defined, crystalline structure. ... so precisely decided that zeolites can separate molecules ... an angstrom (one-tenth of a nanometer), making them ...
(Date:7/24/2014)... , July 24, 2014 SRI International ... with the National Institute of Allergy and Infectious Diseases ... conduct preclinical development of potential therapies for HIV infection ... to treat HIV and AIDS and the complications and ... microbicides for preventing sexual transmission of HIV. ...
(Date:7/24/2014)... N.J. , July 24, 2014 ... provider of regulatory and ethical review services for ... Alliance Biosciences. Formerly a division of ... was the leading biosafety and biosecurity consulting firm ... With this addition, WCG,s biosafety division – WCG ...
Breaking Biology Technology:Asterias Biotherapeutics Announces Live Investor Webcast 2Asterias Biotherapeutics Announces Live Investor Webcast 3Asterias Biotherapeutics Announces Live Investor Webcast 4University of Delaware researcher describes new approach for creating organic zeolites 2National Institute of Allergy and Infectious Diseases Awards SRI International Contract to Study New Therapies for HIV and AIDS 2National Institute of Allergy and Infectious Diseases Awards SRI International Contract to Study New Therapies for HIV and AIDS 3WIRB-Copernicus Group Announces Acquisition of Alliance Biosciences; Executives Join WCG Biosafety Division 2WIRB-Copernicus Group Announces Acquisition of Alliance Biosciences; Executives Join WCG Biosafety Division 3
... Potential Future Application of Stem Cells as a ... Treatment for Diabetes ... Nature Biotechnology, SAN DIEGO, Feb. 20 Novocell, Inc., a stem cell,engineering ... cells can be turned into pancreatic cells,capable of producing insulin in mice. The ...
... PPD, Inc. (Nasdaq:,PPDI) today announced its plans to begin ... common stock may be purchased from time to time,in the ... a share repurchase program in,view of the current price at ... balance sheet and its ability to generate cash,as well as ...
... Rotarix Would be the Only Vaccine Indicated to Prevent, ... Circulating Types, Offering, Completion of the Vaccination by ... GAITHERSBURG, Md. and PHILADELPHIA, Feb. 20 ,GlaxoSmithKline (NYSE: ... Drug,Administration,s (FDA) Vaccines and Related Biological Products Advisory,Committee (VRBPAC) ...
Cached Biology Technology:Novocell Reports Successful Use of Stem Cells to Generate Insulin in Mice 2Novocell Reports Successful Use of Stem Cells to Generate Insulin in Mice 3PPD Announces Plan to Repurchase Shares of its Common Stock 2GSK Receives Favorable Recommendation by FDA Advisory Committee for Rotarix(R) (Rotavirus Vaccine, Live, Oral) 2GSK Receives Favorable Recommendation by FDA Advisory Committee for Rotarix(R) (Rotavirus Vaccine, Live, Oral) 3GSK Receives Favorable Recommendation by FDA Advisory Committee for Rotarix(R) (Rotavirus Vaccine, Live, Oral) 4
BOND ELUT MATRIX-C18, 25 mg ...
Terrific Broth, 1 kg. Mixture of casein peptone, yeast extract, K2HPO4, and KH2PO4.Used at 47 g/l for E. coli growth with higher cell densities. Category: Nucleotides & Enzymes & Biochemicals, Ultrap...
Human VEGF R3/Flt-4 Phycoerythrin MAb (Clone 54733)...
Human Legumain Affinity Purified Polyclonal Ab...
Biology Products: